Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel

Explore the latest updates and expert interviews

The Non-Malignant Channel is supported with funding from Agios (Gold).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Latest Videos Sessions Anemias Autoimmune Disorders Bleeding Disorders Other Disorders Conferences Features Podcasts Expert Editorial Board

Welcome to The Non-Malignant Channel.

Alongside a world-leading Editorial Board, explore the latest updates in non-malignant blood disorders. Speaking directly with the experts at international congresses, The Non-Malignant Channel brings you video interviews, podcasts, roundtable discussions and more.

Conferences

EBMT 2026
CAR-T Meeting 2026
EBMT 2026
ASH 2025
EHA 2025
IPIG 2025
1:17
Exa-cel for sickle cell disease and transfusion-dependent beta thalassemia: a real-world experience
Mohammed Essa • 26 Mar 2026
2:39
Optimizing mobilization and apheresis in preparation for sickle cell gene therapy
Mohammed Essa • 26 Mar 2026
1:10
IgG and immune competence after stem cell transplant in pediatric sickle cell disease
Alexander Ngwube • 23 Mar 2026
1:23
The potential of using abatacept to mitigate transplant-related toxicities in hemoglobinopathies
Alexander Ngwube • 23 Mar 2026
View All Videos
3:47
The potential role of CAR T-cell therapy in acquired hemophilia A
Felicitas Thol • 17 Feb 2026
1:28
Where is the field of CAR-T moving for the treatment of autoimmune diseases?
Raffaella Greco • 5 Feb 2026
4:26
An update on the rapidly evolving field of CAR T-cell therapy in autoimmune diseases
Raffaella Greco • 5 Feb 2026
2:08
Improving patient selection and referral for CAR T-cell therapy in autoimmune diseases
Raffaella Greco • 5 Feb 2026
View All Videos
1:17
Exa-cel for sickle cell disease and transfusion-dependent beta thalassemia: a real-world experience
Mohammed Essa • 26 Mar 2026
2:39
Optimizing mobilization and apheresis in preparation for sickle cell gene therapy
Mohammed Essa • 26 Mar 2026
1:10
IgG and immune competence after stem cell transplant in pediatric sickle cell disease
Alexander Ngwube • 23 Mar 2026
1:23
The potential of using abatacept to mitigate transplant-related toxicities in hemoglobinopathies
Alexander Ngwube • 23 Mar 2026
View All Videos
2:23
Non-opioid and integrative strategies for pain management during VOC in SCD
Claudia Morris • 6 Dec 2025
2:15
Real-world outcomes of patients with cold agglutinin disease
Jahanzaib Khwaja • 8 Dec 2025
2:48
Diagnosing MGRS: the central role of kidney biopsy
Heather Landau • 5 Dec 2025
3:08
Real‑world experience with marstacimab in severe and non‑severe hemophilia
Akshat Jain • 8 Dec 2025
View All Videos
3:51
Using luspatercept in patients with β-thalassemia who convert to transfusion dependence late in life
Maria Dimopoulou • 20 Oct 2025
1:26
Opportunities to combine mitapivat with other therapies in clinical trials
Maria Domenica Cappellini • 15 Jun 2025
2:41
Exploring mitapivat in thalassemia & SCD: the potential upcoming approval of the agent
Maria Domenica Cappellini • 15 Jun 2025
6:38
Results of the SATISFY trial investigating mitapivat in erythrocyte membranopathies and CDA II
Thomas Doeven • 12 Jun 2025
View All Videos
2:24
A Phase IV trial assessing the switch from high-dose eculizumab to weight-based ravulizumab in PNH
Austin Kulasekararaj • 15 May 2025
1:52
The impacts of PNH and symptoms that clinicians should be aware of
Richard Kelly • 15 May 2025
0:35
Aims of the new IPIG registry: advancing the understanding of PNH biology and treatment
Jeff Szer • 15 May 2025
0:54
The current treatment landscape of PNH in Germany and across Europe
Jens Panse • 15 May 2025
View All Videos

The Non-Malignant Channel is supported with funding from Agios (Gold).

Gold Supporter

Agios

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

If you are interested in becoming a supporter of The Non-Malignant Channel, please contact us.

The content of VJHemOnc is intended for healthcare professionals